1. Tubulointerstitial capillaries limited intravascular lymphoma of the kidney

   • Yuya Kimura
   • Masami Takeuchi
   • Kosei Matsue

   Images in Hematology 28 July 2017 Pages: 589 - 590

   

2. JSH guideline for tumors of hematopoietic and lymphoid tissues—lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN)

   • Noriko Usui

   Guide Line 21 September 2017 Pages: 591 - 611

3. Effect of rituximab on primary central nervous system lymphoma: a meta-analysis

   • Yue Song
   • Yibo Wen
   • Mingzhi Zhang

   Review Article 12 September 2017 Pages: 612 - 621

   

4. Screening novel autoantigens targeted by serum IgG autoantibodies in immunorelated pancytopenia by SEREX

   • Shanfeng Hao
   • Rong Fu
   • Zonghong Shao

   Original Article 07 July 2017 Pages: 622 - 630

   

5. CD34-negative hematopoietic stem cells show distinct expression profiles of homing molecules that limit engraftment in mice and sheep

   • Tomoyuki Abe
   • Yoshikazu Matsuoka
   • Yutaka Hanazono

   Original Article 07 July 2017 Pages: 631 - 637

   

6. MiR-155 enhances phagocytic activity of β-thalassemia/HbE monocytes via targeting of BACH1

   • Kanitta Srinoun
   • Chamnong Nopparatana
   • Suthat Fucharoen

   Original Article 06 July 2017 Pages: 638 - 647

   

7. Plasma chitotriosidase and carotid intima–media thickness in children with sickle cell disease

   • Normeen A. Kaddah
   • Dalia A. Saied
   • Mohamed A. Elmonem

   Original Article 04 July 2017 Pages: 648 - 654

   

8. Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study

   • Dai Maruyama
   • Kensei Tobinai
   • Tomoko Ohtsu

   Original Article 29 June 2017 Pages: 655 - 665

   

9. NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib

   • Ryujiro Hara
   • Makoto Onizuka
   • Kiyoshi Ando

   Original Article 09 August 2017 Pages: 666 - 674

   

10. Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997–2016

    • Akiko Miyagi Maeshima
    • Hirokazu Taniguchi
    • Kensei Tobinai

    Original Article 18 September 2017 Pages: 675 - 680

    

11. Retrospective analysis of prognostic factors for Waldenstrӧm macroglobulinemia: a multicenter cooperative study in Japan

    • Akio Saito
    • Atsushi Isoda
    • Norifumi Tsukamoto

    Original Article 07 July 2017 Pages: 681 - 690

    

12. Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms

    • Yasuhiro Taniguchi
    • Hirokazu Tanaka
    • Itaru Matsumura

    Original Article 05 August 2017 Pages: 691 - 703

    

13. Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations

    • Keiji Nogami
    • Midori Shima
    • Barbara A. Konkle

    Original Article 26 May 2017 Pages: 704 - 710

14. Congenital immature pure erythroid leukemia with E-cadherin expression

    • Akihiro Tamura
    • Suguru Uemura
    • Yoshiyuki Kosaka

    Case Report 18 May 2017 Pages: 711 - 717

    

15. Steroid-resistant autoimmune myelofibrosis in a patient with autoimmune hepatitis and Evans syndrome complicated with increased expression of TGF-β in the bone marrow: a case report

    • Hiroshi Ohkawara
    • Miki Furukawa
    • Takayuki Ikezoe

    Case Report 05 June 2017 Pages: 718 - 724

    

16. Correction to: JSH guideline for tumors of hematopoietic and lymphoid tissues—lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN)

    • Noriko Usui

    Correction 12 October 2017 Pages: 725 - 725